The Contribution of Executive Control on Verbal-Learning Impairment in Patients with Parkinson's Disease with Dementia and Alzheimer's Disease

被引:11
|
作者
O'Brien, Timothy J. [1 ]
Wadley, Virginia [1 ,3 ]
Nicholas, Anthony P. [2 ,3 ]
Stover, Natividad P. [2 ]
Watts, Ray [2 ]
Griffith, H. Randall [1 ,2 ,3 ]
机构
[1] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Alzheimers Dis Res Ctr, Birmingham, AL 35294 USA
关键词
Parkinson's disease with dementia; Alzheimer's disease; Executive function; List learning; Neuropsychologic tests; Comparative studies; DIFFERENTIAL IMPACT; MEMORY IMPAIRMENT; DYSFUNCTION; PREVALENCE; DEFICITS;
D O I
10.1093/arclin/acp029
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Deficits in learning, memory, and executive functions are common cognitive sequelae of Parkinson's disease with dementia (PDD) and Alzheimer's disease (AD); however, the pattern of deficits within these populations is distinct. Hierarchical regression was used to investigate the contribution of two measures with executive function properties (Verbal Fluency and CLOX) on list-learning performance (CVLT-II total words learned) in a sample of 25 PDD patients and 25 matched AD patients. Executive measures were predictive of list learning in the PDD group after the contribution of overall cognition and contextual verbal learning was accounted for, whereas in the AD group the addition of executive measures did not add to prediction of variance in CVLT-II learning. These findings suggest that deficits in executive functions play a vital role in learning impairments in patients with PDD; however, for AD patients, learning difficulties appear relatively independent of executive dysfunction.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 50 条
  • [41] Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia
    Szeto, Jennifer Y. Y.
    Lewis, Simon J. G.
    CURRENT NEUROPHARMACOLOGY, 2016, 14 (04) : 326 - 338
  • [42] Heterogeneity of Letter Fluency Impairment and Executive Dysfunction in Parkinson's Disease
    Pettit, Lewis
    McCarthy, Martina
    Davenport, Richard
    Abrahams, Sharon
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2013, 19 (09) : 986 - 994
  • [43] Analysis of the Substantia Innominata Volume in Patients with Parkinson's Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer's Disease
    Kim, Hee Jin
    Lee, Ji Eun
    Shin, Soo Jeong
    Sohn, Young Ho
    Lee, Phil Hyu
    JOURNAL OF MOVEMENT DISORDERS, 2011, 4 (02) : 68 - 72
  • [44] Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test
    Allone, Cettina
    Lo Buono, Viviana
    Corallo, Francesco
    Bonanno, Lilla
    Palmeri, Rosanna
    Di Lorenzo, Giuseppe
    Marra, Angela
    Bramanti, Placido
    Marino, Silvia
    PSYCHOGERIATRICS, 2018, 18 (02) : 123 - 131
  • [45] The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia
    Lee, Wei-Ju
    Tsai, Chia-Fen
    Gauthier, Serge
    Wang, Shuu-Jiun
    Fuh, Jong-Ling
    INTERNATIONAL PSYCHOGERIATRICS, 2012, 24 (12) : 1980 - 1987
  • [46] Everyday Action Impairment in Parkinson's Disease Dementia
    Giovannetti, Tania
    Britnell, Priscilla
    Brennan, Laura
    Siderowf, Andrew
    Grossman, Murray
    Libon, David J.
    Bettcher, Brianne M.
    Rouzard, Francesca
    Eppig, Joel
    Seidel, Gregory A.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2012, 18 (05) : 787 - 798
  • [47] Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease
    Goldman, Jennifer G.
    Aggarwal, Neelum T.
    Schroeder, Cynthia D.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (05) : 425 - 443
  • [48] Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies
    Broadstock, Martin
    Ballard, Clive
    Corbett, Anne
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (13) : 1797 - 1810
  • [49] Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: Similarities and differences
    Emre, Murat
    Cummings, Jeffrey L.
    Lane, Roger M.
    JOURNAL OF ALZHEIMERS DISEASE, 2007, 11 (04) : 509 - 519
  • [50] Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease
    Sabbagh, M. N.
    Lahti, T.
    Connor, D. J.
    Caviness, J. N.
    Shill, H.
    Vedders, L.
    Mahant, P.
    Samanta, J.
    Burns, R. S.
    Evidente, V. G. H.
    Driver-Dunckley, E.
    Reisberg, B.
    Bircea, S.
    Adler, C. H.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (05) : 327 - 334